医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MMS Named a Great Place to Work in India

2023年01月12日 PM01:30
このエントリーをはてなブックマークに追加


 

BANGALORE, India

MMS Holdings, a data-focused contract research organization (CRO), has been named a Great Place to Work by the Great Place to Work Institute of India.

This award is based on anonymous feedback from a survey sent out to employees and measures the quality of employee experience, the strength of leadership, the quality of the practices and programs that shape employee experience, and the levels of trust that enable everyone to use their potential.

Over 87% of MMS employees completed the survey, and based on their feedback, MMS was recognized as demonstrating the excellent workplace culture needed for success.

“We are honored to be named a Great Place to Work in India, especially because our colleagues determined the result,” said Uma Sharma, Ph.D., Chief Executive Officer at MMS. “Our colleagues in India play a key role in our global #OneMMS strength, and it is through their embodiment of our core values and mission that we achieve success.”

“We wouldn’t have achieved this recognition without our dedicated leaders at all levels,” said Uma Nathan, Executive Head of India Operations at MMS. “The strength of our #OneMMS team is the help we extend to our colleagues across the globe, so we can focus on solutions and making a difference in the lives of patients.”

“MMS continues to strive to provide the best work culture to our colleagues,” said Nandini Vijaisimha, Director of Human Resources at MMS. “We believe in nurturing a creative environment and helping our colleagues by establishing a culture where people can be innovative.”

About MMS

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, including offices in Bangalore and Hyderabad, MMS maintains one of the highest retention rates in the industry.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005679/en/

CONTACT

Prakash Achaary

media@mmsholdings.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series
  • Kyocera Develops New “Contactless Intelligent Millimeter-Wave Sensing System”
  • Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera
  • Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3
  • 武田薬品工業: パイプラインの進展と2つのターゲットを絞った取得案件により長期的成長に向け加速、2022年度第3四半期も力強い業績を達成